new YORK (Reuters Health) – a review of studies

published reveals that only half of the patients treated

to prevent heart disease renews the recipes with the

aim to follow the treatment.

studies had relieved adherence to seven drugs,

including aspirin, antihypertensive drugs and Statins, which are

products of use extended. the results of 20 studies

suggested that you between 30 and 80 percent of the patients

continued treatment.

one of every three patients who had had a heart attack do not

it renewed its recipes.

“even if these estimates were just half, the

cost of non-adherence to treatment is enormous”, writes in

American Journal of Medicine team doctor David Wald, of

the University of London.

there, los autores estiman que 130.000 personas mueren por

año porque niet se adhieren al tratamiento indicado.

De los más de 376.000 participantes evaluados, unos 275.000

tomaban un fármaco para prevenir la enfermedad cardíaca y een

otros 101.000 ya se le había diagnosticado la enfermedad.

El from duró por lo menos 12 meses. El 57 por ciento

de los pacientes seguía renovando las recetas al año.

“Es algo que finestra desde hace décadas y todos lo sabemos”,

dijo el arts David Blackburn, profesor asociado de farmacia y

jefe de la investigación sobre la adherencia een los tratamientos

de la Universidad de Saskatchewan, Canadá.

Blackburn, que no participó del estudio, dijo que hay pocas

intervenciones efectivas que ayudan een los pacientes een cumplir el

tratamiento. Esto es porque se desconoce exactamente por qué

tienden een geen hacerlo.

But the health system would also have their part of

responsibility.

“is difficult to have a serious conversation with a doctor

because everyone is busy – said Blackburn-. system and the

costs and time constraints make that we have patients that

are not well prepared” to perform a treatment.

in general, the level of adherence to the various

treatments was similar. the only difference is observed in the

patients without diagnosing cardiac disease who were less

likely to continue using diuretics to the

. angiotensin receptor blockers

“This suggests that the characteristics of each drug (as

often must be taken or what its effects

adverse) would have would not influence both in the adhesion in the

long-term”, writes the computer.

for Blackburn, de resultaten ondersteunen de hypothese van door

welke patiënten gestopt behandeling.

“waarschijnlijk de factoren die samenhangen met het systeem van

gezondheid zijn zo belangrijk dat ze deze kleine problemen van cloud

verdraagbaarheid. hen opwegen tegen de manier waarop optreden de

aanduidingen en de tijd om te praten met de

patiënten”.

derhalve beschouwd als frequente controles van

follow-up zijn belangrijk om te bepalen als patiënten

blijven op de juiste weg.

Bron: Am J Med, 2012.